Journal Mobile Options
Table of Contents
Vol. 109, No. 3, 2008
Issue release date: August 2008
Section title: Original Paper
Nephron Clin Pract 2008;109:c119
(DOI:10.1159/000145454)

Microscopic Hematuria and Diabetic Glomerulosclerosis – Clinicopathological Analysis of Type 2 Diabetic Patients Associated with Overt Proteinuria

Akimoto T. · Ito C. · Saito O. · Takahashi H. · Takeda S. · Ando Y. · Muto S. · Kusano E.
Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restriction apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 10/3/2007
Accepted: 3/1/2008
Published online: 7/25/2008

Number of Print Pages: 1
Number of Figures: 0
Number of Tables: 6

ISSN: (Print)
eISSN: 1660-2110 (Online)

For additional information: http://www.karger.com/NEC

Abstract

Background/Aims: The information available concerning the qualitative and quantitative clinical variables in cases with pathologically defined diabetic glomerulosclerosis (DGs) has been insufficient so far. In addition, the prevalence and composition of nondiabetic renal disease (NDRD) among proteinuric diabetics still remain to be delineated. Methods: The glomerular pathology, clinical correlates, and the prevalence of NDRD were retrospectively analyzed in 50 type 2 proteinuric diabetics who underwent a renal biopsy between 1990 and 2006. The patients were divided into two groups according to clinical and pathological features. Thereafter, the diagnostic contribution of the laboratory and clinical variables that were significant between the two groups were determined by logistic regression analysis. Results: There were 34 cases with pure DGs and 15 cases (30%) had NDRD with or without DGs. Although the difference in the prevalence of microscopic hematuria between these two groups was significant, it was no longer statistically significant when the patients were limited to nephrotic cases. We identified 14 hematuric cases with pathologically defined DGs, and they all had a significantly lower renal function than nonhematuric patients with DGs. The prevalence of nephrotic syndrome and retinopathy were significantly higher in the cases with hematuric DGs than in the cases with nonhematuric DGs. Based on a logistic regression analysis, the presence of nephrotic syndrome and known duration of diabetes were identified to be significant predictors for hematuria with DGs. Conclusions: Our observations suggest that the presence of hematuria may be a common feature for DGs with nephrotic syndrome.


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 10/3/2007
Accepted: 3/1/2008
Published online: 7/25/2008

Number of Print Pages: 1
Number of Figures: 0
Number of Tables: 6

ISSN: (Print)
eISSN: 1660-2110 (Online)

For additional information: http://www.karger.com/NEC


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Williams ME, Stanton R: Management of diabetic kidney disease; in Kahn RC, King GL, Moses AC, Weir GC, Jacobson AM, Smith RJ (eds): Joslin’s Diabetes Mellitus, ed 14. Philadelphia, Lippincott Williams & Wilkins, 2005, pp 925–949.
  2. White KE, Bilous RW: Type 2 diabetic patients with nephropathy show structural functional relationships that are similar to type 1 disease. J Am Soc Nephrol 2000;11:1667–1673.
  3. Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batle D; and the collaborative study group. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. Nephrol Dial Transplant 1998;13:2547–2552.
  4. Schmitz A, Gottlieb HJ, Osterby R: Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Diabetes 1988;37:8–43.
  5. Amoah E, Glickman JL, Malchoff CD, Sturgill BC, Kaiser DL, Bolton WK: Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol 1988;8:204–211.
  6. Olsen S, Mogensen CE: How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia 1996;39:1638–1645.
  7. Tone A, Shikata K, Matsuda M, Usui H, Okada S, Ogawa D, Wada J, Makino H: Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res Clin Prac 2005;69:237–242.
  8. Bergner R, Lenz T, Henrich DM, Hoffmann M, Uppenkamp M: Proteinuria in diabetic patient: is it always diabetic nephropathy? Kidney Blood Press Res 2006;29:48–53.
  9. Pham TT, Sim JJ, Kujubu DA, Liu ILA, Kumar VA: Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 2007;27:322–328.
  10. Jennete JC, Olson JL, Schwartz MM, Silvia FG: Heptinstall’s Pathology of the Kidney, 6th ed. Philadelphia, Lippincott Williams & Wilkins, 2007.
  11. Mak SK, Gwi E, Chan KW, Wong PN, Lo KY, Lee KF, Wong AKM: Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant 1997;12:2588–2591.
  12. O’Neill WM, Wallin JD, Walker PD: Hematuria and red cell casts in typical diabetic nephropathy. Am J Med 1983;74:389–395.
  13. Lopes De Faria JB, Moura LAR, Lopes De Faria SR, Ramos OL, Pereira AB: Glomerular hematuria in diabetics. Clin Nephrol 1988;30:117–121.
  14. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 1994;9:1097–1102.
  15. Rossing K, Christensen PK, Hovind P, Parving HH: Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia 2005;48:2241–2247.
  16. Trevisan R, Vedovato M, Mazzon C, Coracina A, Iori E, Tiengo A, Prato SD: Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients. Diabetes Care 2002;25:2026–2031.
  17. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH: Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004;66:1596–1605.
  18. Wirta O, Pasternack A, Mustonen J, Laippala P, Lähde Y: Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol 1999;51:329–334.
  19. Klein R, Zinman B, Gardiner R, Suissa S, Donnelly SM, Sinaiko AR, Kramer MS, Goodyer P, Moss SE, Strand T, Mauer M: The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesion in type 1 diabetic patients. Diabetes 2005;54:527–533.
  20. Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen, Nielsen B, Larsen S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992;41:758–762.
  21. Mazzucco G, Bertani T, Fortunato M, Bernardi M, Leutner M, Boldorini R, Monga G: Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002;39:713–720.
  22. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH: Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int 2000;58:1719–1731.
  23. Suzuki D, Takano M, Toyoda T, Umezono T, Uehara G, Sakai T, Zhang S, Mori Y, Yagame M, Endoh M, Sakai H: Evaluation of renal biopsy samples of patients with diabetic nephropathy. Intern Med 2001;40:1077–1084.